News & AnalysisClinical Trials

Europe Debates Ethics Reviews, Data Release

See allHide authors and affiliations

Science  01 Mar 2013:
Vol. 339, Issue 6123, pp. 1024
DOI: 10.1126/science.339.6123.1024

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


European countries are embroiled in a debate over how to redo rules for clinical trials, an effort to replace a controversial 12-year-old directive that critics say bound human research studies in red tape. But preserving stringent patient protections without tipping into excessive bureaucracy—and getting 27 countries to agree—is no easy task.